Cargando…

Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma

Clinical evaluation, differential diagnosis, and management of a neck mass constitute commonly encountered problems for the head and neck surgeon. An asymptomatic neck mass in adults may be the only clinical sign of head and neck cancer. A 50-year-old female patient presented with a painless, slowly...

Descripción completa

Detalles Bibliográficos
Autores principales: Karatzanis, Alexander, Mylopotamitaki, Kleanthi, Lagoudaki, Eleni, Prokopakis, Emmanuel, Agelaki, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529529/
https://www.ncbi.nlm.nih.gov/pubmed/36199676
http://dx.doi.org/10.1155/2022/4582262
_version_ 1784801515567841280
author Karatzanis, Alexander
Mylopotamitaki, Kleanthi
Lagoudaki, Eleni
Prokopakis, Emmanuel
Agelaki, Sofia
author_facet Karatzanis, Alexander
Mylopotamitaki, Kleanthi
Lagoudaki, Eleni
Prokopakis, Emmanuel
Agelaki, Sofia
author_sort Karatzanis, Alexander
collection PubMed
description Clinical evaluation, differential diagnosis, and management of a neck mass constitute commonly encountered problems for the head and neck surgeon. An asymptomatic neck mass in adults may be the only clinical sign of head and neck cancer. A 50-year-old female patient presented with a painless, slowly enlarging, left lateral neck lump. Ultrasonography described a possible lymph node with cystic degeneration, and fine needle aspiration biopsy only detected atypical cells of squamous epithelium. An open biopsy under general anesthesia was performed. Histopathological findings suggested the diagnosis of lymph node infiltration by squamous cell carcinoma of an unknown primary site, but differential diagnosis also included branchiogenic carcinoma arising in a branchial cleft cyst. A diagnostic algorithm for metastatic squamous cell carcinoma of an unknown primary site was followed, including positron emission tomography with computed tomography. The patient underwent panendoscopy and bilateral tonsillectomy, and an ipsilateral p16 positive tonsillar squamous cell carcinoma was detected. Further appropriate management followed. The existence of true branchiogenic carcinoma is controversial. When such a diagnosis is contemplated, every effort should be made to detect a possible primary site. Branchiogenic carcinoma, if exists at all, remains a diagnosis of exclusion.
format Online
Article
Text
id pubmed-9529529
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95295292022-10-04 Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma Karatzanis, Alexander Mylopotamitaki, Kleanthi Lagoudaki, Eleni Prokopakis, Emmanuel Agelaki, Sofia Case Rep Otolaryngol Case Report Clinical evaluation, differential diagnosis, and management of a neck mass constitute commonly encountered problems for the head and neck surgeon. An asymptomatic neck mass in adults may be the only clinical sign of head and neck cancer. A 50-year-old female patient presented with a painless, slowly enlarging, left lateral neck lump. Ultrasonography described a possible lymph node with cystic degeneration, and fine needle aspiration biopsy only detected atypical cells of squamous epithelium. An open biopsy under general anesthesia was performed. Histopathological findings suggested the diagnosis of lymph node infiltration by squamous cell carcinoma of an unknown primary site, but differential diagnosis also included branchiogenic carcinoma arising in a branchial cleft cyst. A diagnostic algorithm for metastatic squamous cell carcinoma of an unknown primary site was followed, including positron emission tomography with computed tomography. The patient underwent panendoscopy and bilateral tonsillectomy, and an ipsilateral p16 positive tonsillar squamous cell carcinoma was detected. Further appropriate management followed. The existence of true branchiogenic carcinoma is controversial. When such a diagnosis is contemplated, every effort should be made to detect a possible primary site. Branchiogenic carcinoma, if exists at all, remains a diagnosis of exclusion. Hindawi 2022-09-16 /pmc/articles/PMC9529529/ /pubmed/36199676 http://dx.doi.org/10.1155/2022/4582262 Text en Copyright © 2022 Alexander Karatzanis et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Karatzanis, Alexander
Mylopotamitaki, Kleanthi
Lagoudaki, Eleni
Prokopakis, Emmanuel
Agelaki, Sofia
Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma
title Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma
title_full Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma
title_fullStr Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma
title_full_unstemmed Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma
title_short Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma
title_sort clinical controversy surrounding the differential diagnosis of branchiogenic carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529529/
https://www.ncbi.nlm.nih.gov/pubmed/36199676
http://dx.doi.org/10.1155/2022/4582262
work_keys_str_mv AT karatzanisalexander clinicalcontroversysurroundingthedifferentialdiagnosisofbranchiogeniccarcinoma
AT mylopotamitakikleanthi clinicalcontroversysurroundingthedifferentialdiagnosisofbranchiogeniccarcinoma
AT lagoudakieleni clinicalcontroversysurroundingthedifferentialdiagnosisofbranchiogeniccarcinoma
AT prokopakisemmanuel clinicalcontroversysurroundingthedifferentialdiagnosisofbranchiogeniccarcinoma
AT agelakisofia clinicalcontroversysurroundingthedifferentialdiagnosisofbranchiogeniccarcinoma